TMS Offers New Option to Counteract Suicide Rate
Depression affects 450 million people worldwide and 15 million adults in the U.S. alone, with suicide being the tenth leading cause of...
top of page
News & Events
Sep 28, 2018
New U Therapy Expands Deep TMS to Santa Clarita
The results of TMS clinical trials report that 44% of treatment-resistant patients achieved a positive response after the full course of...
Sep 19, 2018
BrainsWay’s TMS Device Cleared for OCD Treatment
The Food and Drug Administration has recently cleared Deep TMS treatment to treat those suffering from Obsession Compulsive Disorder...
Sep 12, 2018
Dr. Oscar Morales Interviewed by Health Professional Radio
Dr. Oscar Morales, psychiatrist and Senior Medical Advisor at Achieve TMS East, is interviewed by Health Professional Radio on the use of...
Sep 5, 2018
ADHD Patient Participates in TMS Clinical Trial
A young woman suffering from ADHD didn’t like the idea of medicating herself, so subsequently enrolled in a clinical trial for Deep TMS...
Aug 29, 2018
HPR Treatment Centers Expands Use of Deep TMS Throughout the US
HPR Treatment Centers, from its beginnings in Hackensack, NJ, has expanded from coast to coast, and is leveraging BrainsWay Deep TMS...
Aug 27, 2018
BrainsWay Reports Financial Results for Second Quarter of 2018 and Provides Corporate Update
Second quarter revenues of $3.7 million represent a quarterly record and a 57% increase over second quarter 2017 Recently announced FDA...
Aug 19, 2018
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive Comp
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive Compulsive Disorder BrainsWay’s deep...
Jun 25, 2018
Jersey Matters Features MDD Patient Helped by Integrative Behavioral Care & BrainsWay
With only one out of every three patients using antidepressants achieve remission, its no secret why more and more patients suffering...
Jun 7, 2018
BrainsWay and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic
BrainsWay and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder Unique Biomarkers...
May 30, 2018
BrainsWay Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update
First quarter revenues of $3.6 million represent a quarterly record and a 68% increase over first quarter 2017 Increased market demand...
May 23, 2018
Achieve TMS Announces Grand Opening of New Location in Newton, Massachusetts
NEWTON, Mass., May 23, 2018 (GLOBE NEWSWIRE) — Achieve TMS, the largest U.S. provider of BrainsWay’s Deep Transcranial Magnetic...
May 6, 2018
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transc...
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS)...
Apr 9, 2018
Health Care and Hospitals Opening Up to TMS
Not only have private practices been experiencing success with TMS, but hospitals have been as well according to Carlos Rueda, the MD...
Dec 12, 2017
BrainsWay Raises $8.5 Million From Leading Israeli Investors
Phoenix Group becomes 7% shareholder. financing strengthens BrainsWay’s balance sheet and provides strong support for continued growth...
Nov 20, 2017
BrainsWay Reports Record Quarterly Revenues in Third Quarter of 2017
ncreased market demand and new leasing model continue to generate significant sales growth Recently signed contracts increased total...
Oct 19, 2017
The stock in the spotlight: BrainsWay
Sponsor Editoriial Board “The transition to focusing on the leasing business model helps us continue increasing the revenues we receive...
Aug 23, 2017
BrainsWay Reports Continued Successful Implementation of its New Business Model in Second Quarter of
BrainsWay Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017 Backlog revenues due to future...
bottom of page